
Gowthami M. Arepally, M.D. is a Professor of Medicine in the Division of Hematology at Duke University Medical Center. Her clinical interests are in immune thrombocytopenias, thrombotic disorders, and complement-mediated diseases. Dr. Arepally’s long-standing research program investigates the immune pathogenesis of heparin induced thrombocytopenia (HIT). Current laboratory efforts focus on the role of complement activation in antibody production and thrombosis in HIT, studies of complement inhibitors for immune-complex mediated diseases and diagnostic biomarkers of platelet activation.
Education and Training
- Fellow in Hematology-Oncology, Medicine, University of Pennsylvania, 1993 - 1997
- Chief Medical Resident, Medicine, Emory University, 1992 - 1993
- Medical Resident, Medicine, Emory University, 1989 - 1992
- M.D., Vanderbilt University, 1989
Grants
- Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient Mortality
- Hematology & Transfusion Medicine (T32)
- Complement and Thrombosis in HIT
- Unified Program for Therapeutics in Children
- An Acoustofluidic Device for Biocompatible Platelet Separation
- Duke CTSA (TL1) Year 5
- Novel development ofan acoustofluidic device for targeted antibody removal in pediatric organ transplan rejection
- Acoustic Device to Prevent Antibody Mediated Organ Transplant Failure
- Platelet Kinetics in Acute Thrombus Formation in Healthy and VTE Patients
- Role of Complement Receptors in cellualr activation by HIT immune complexes
- Duke Resident Physician-Scientist Program- NHLBI